Precision Ocular Care: Integrating Oncology and Eyecare to Conquer ADC-Related Toxicities
Webinar/Online
Wednesday, February 11, 2026 at 2:00pm ET - 3:00pm ET
Add this event to your calendar
Info
Topic
Join our live national webinar led by expert oncologists and eye specialists to master the multidisciplinary management of ocular adverse events that some patients may experience when receiving antibody-drug conjugates (ADCs) and targeted therapies for cancer treatment. Hear expert perspectives on key findings from new surveys of oncology providers and eye care specialists, along with real-world insights from a recent regional clinic-based series. This session will feature the expert analysis of the latest clinical trial data, case-based discussion, actionable strategies for optimizing collaboration between the oncology care team and eye care specialists, and point-of-care resources for clinical practice.
Credits Offered
This event offers
1.0 contact hour
to attendees.
Accreditation Info:
AANP.
Additional Information
Join our live national webinar led by expert oncologists and eye specialists to master the multidisciplinary management of ocular adverse events that some patients may experience when receiving ADCs and targeted therapies for cancer treatment.
Speakers
Professor of Oncology
Department of Medicine
Roswell Park Comprehensive Cancer Center
Professor
Vice Chair for Academic Affairs
Director of Medical Student Education
Department of Ophthalmology and Visual Science
University of Chicago
Dr. Asim V. Farooq is a Professor, Vice Chair for Academic Affairs, and Director of Medical Student Education, in the Department of Ophthalmology and Visual Science at the University of Chicago. He received his medical degree from the University of Illinois College of Medicine - during his time there, he was awarded a grant from Research to Prevent Blindness, allowing him to devote a year to study the pathogenesis of herpes simplex virus (HSV) infections in the cornea. He then completed ophthalmology residency training at the University of Illinois Eye and Ear Infirmary, and a fellowship in cornea and external disease at the Washington University in St. Louis. Dr. Farooq has published approximately 70 peer-reviewed articles as well as numerous abstracts and book chapters, and has been an invited speaker nationally and internationally. He also hold several extramural positions, including with the Eye Bank Association of America (Committee Chair) and the Chicago Ophthalmological Society (President). His clinical and research interests are focused on ocular adverse events from targeted chemotherapeutic agents, viral infections of the cornea, and ocular graft versus host disease.